3D structure | enzyme inhibition | enzyme mechanism | glycobiology | glycosidase N -linked glycans are present on the majority of eukaryotic proteins and direct their folding and influence their stability. These polysaccharide decorations play important roles in processes such as protein folding, targeting, antigenicity, and lectin interactions, with defects leading to cellular dysfunction (1) . Aberrant N-glycan composition, through either incorrect or incomplete processing, is associated with various conditions, including Alzheimer's disease, congenital disorders of glycosylation, viral infection, and metastatic cancer progression (2) (3) (4) . Alteration of N-glycan biosynthesis in cancerous cells and by human pathogenic viruses renders the various proteins involved in their biosynthesis and modification therapeutic targets. N-glycans are built-up and then "biosynthetically" degraded in an orchestrated process involving synthetic enzymes (glycosyltransferases) and catabolic enzymes (glycoside hydrolases) (5) (Fig. S1 ). Efforts to control diseases of glycoprotein biosynthesis have largely focused on the use of inhibitors of the "biosynthetic" trimming glycoside hydrolases involved in the early stages of N-glycan remodeling, such as glucosidases I and II. However, the failure of these inhibitors to provide an effective treatment of these conditions likely occurs, in part, because of a unique enzyme, endo-α-mannosidase, which cleaves mannoside linkages internally, within the first branch of an N-glycan chain (6) (7) (8) .
N-glycans are covalently bound to the side-chain nitrogen of asparagine (Asn) residues in the consensus Asn-Xxx-Ser/Thr (9) . Within the endoplasmic reticulum (ER), presynthesized 14-mer glycans are cotranslationally transferred en bloc by the multiprotein complex oligosaccharyltransferase from the glycophospholipid precursor, Glc 3 Man 9 GlcNAc 2 -diphospho-dolichol, to Asn residues within nascent polypeptide chains (Fig. S1A) . The initial processing steps of this 14-sugar glycan commence while the unfolded glycoprotein remains attached to the ribosome, and involves the sequential removal of the terminal α-1,2-glucose by glucosidase I and removal of both the subsequent and final α-1,3-glucose moieties by glucosidase II, a procedure normally required for the formation of mature N-glycans (1, 5, 10) (Fig. S1B) . Under normal conditions, the final α-1,3-glucose residue represents a checkpoint in protein folding and quality control because monoglucosylated immature N-glycans with a terminal α-Glc-1,3-α-Man-1,2-α-Man chain are ligands for the molecular chaperones calnexin (CNX) and calreticulin (CRT) (11) . The fate of newly synthesized glycoproteins is determined by a molecular inspection process that monitors their folding state. Correctly folded proteins exit the CNX/CRT cycle with removal of the final α-1,3-glucose from the Man 9 GlcNAc 2 polysaccharide followed by α-mannosidase I cleavage of a mannose residue from the first branch and translocation to the Golgi apparatus. Misfolded proteins undergo cycles of deglucosylation and reglucosylation, catalyzed by luminal UDP-glucose-dependent glycoprotein glycosyltransferase. Terminally misfolded proteins are extracted from the folding cycle in a process termed ER-associated degradation and are retrotranslocated to the cytosol, where they are ubiquitinylated and proteasomally degraded.
Endo-α-mannosidase (classified into Carbohydrate-Active Enzymes Database family GH99; refs. 12 and 13; www.cazy.org) provides a glucosidase I and II independent pathway for the maturation of N-glycans (14) . Endo-α-mannosidase hydrolyzes the α-1,2-mannosidic bond between the glucose-substituted mannose and the remainder of the N-glycan, and acts on the structures Glc 1-3 Man 9 GlcNAc 2 as well as structures that have been trimmed by mannosidases in the 6′-pentamannosyl branch, releasing Glc 1-3 -1,3-α-Man oligosaccharides (15) (Fig. S1C) . Despite growing insight into the biosynthetic function and subcel-lular localization of endo-α-mannosidase (14) , no structures have been reported and nothing is known about its catalytic mechanism. Endo-α-mannosidase therefore represents an important enzyme for further study, with the ultimate goal of developing approaches to treat diseases involving aberrant N-glycosylation. We present a structural and kinetic analysis of two GH99 endo-α-mannosidase enzymes from the enteric bacteria Bacteroides thetaiotaomicron (BtGH99) and Bacteroides xylanisolvens (BxGH99), the first structures for any GH99 enzyme. We show that these protein orthologs are endo-α-mannosidases active on glucosylated N-glycans and perform catalysis with a net retention of anomeric configuration. Structures of complexes obtained with two aza/imino sugar inhibitors reveal intimate details of the catalytic residues, allowing the proposal of a unique blueprint for catalysis and providing a structural rationale for inhibition in both a mechanistic context and ultimately for the development of therapeutic agents.
Results
Activity and Kinetics of GH99 Endo-α-Mannosidase. B. thetaiotaomicron and B. xylanisolvens GH99 enzymes display 42% and 41% sequence identity, respectively, to Homo sapiens endo-α-mannosidase (sequence alignments in Fig. S2 ). In order to ascertain whether the Bacteroides enzymes were appropriate models of the human enzyme, activity on GlcMan 9 GlcNAc 2 was studied by mass spectrometry. Both BtGH99 and BxGH99 catalyze the removal of a disaccharide from GlcMan 9 GlcNAc 2 , with peaks observed for both reaction products, yet have no activity on the unglucosylated substrate Man 9 GlcNAc 2 , indicative of conversion to Man 8 GlcNAc 2 through release of a disaccharide, likely GlcMan (Fig. 1A) . We next studied the BtGH99-catalyzed hydrolysis of a fluorescently labeled mammalian glycan, Glc 3 Man 7 GlcNAc 2 by normal phase HPLC (see SI Methods). BtGH99 shows biologically relevant activity against this substrate with K m and k cat ∕K m values of 83 μM and 2.6 s −1 mM −1 , respectively (Fig. S3 ). These data are in good agreement with the K m value of 55 μM determined for the rat liver enzyme studied by Lubas and Spiro (16) . Thus, BtGH99 possesses specific α-1,2-mannosidase activity when the −1 position mannoside is modified by one or more α-1,3-linked glucose residues. No activity was observed on a range of aryl α-mannosides. To further probe the activity of this enzyme, the activated substrate, α-glucopyranosyl-1,3-α-mannopyranosyl fluoride (Glc-ManF), was synthesized (see SI Methods). Hydrolysis of Glc-ManF releases fluoride, which is monitored using a fluoride ion-selective electrode. BtGH99 shows high activity against Glc-ManF with K m and k cat ∕K m values of 0.48 mM and 9.9 s −1 mM −1 (Fig. 1B) . Although fluoride detection is constrained to a relatively limited pH range, further observation of this reaction across the pH range 5.5-7.5 revealed the enzyme to be optimally active at approximately pH 7.0, consistent with another bacterial homolog from Shewanella amazonensis (17) . That Glc-ManF acts as a substrate although various aryl mannosides do not, coupled with activity on GlcMan 9 GlcNAc 2 and Glc 3 Man 9 GlcNAc 2 , confirms BtGH99 as an endo-α-mannosidase with a requirement for a minimal α-1,3-linked disaccharide substrate and hence with obligate binding for catalysis in a −2 subsite (for subsite nomenclature see ref. 18) .
Further evidence for subsite specificity and the requirement for a minimal occupancy of the −2 and −1 subsites was obtained through binding of two BtGH99 inhibitors. α-Glucopyranosyl-1,3-deoxymannojirimycin (Glc-DMJ) (Fig. 1C) is in widespread use as a specific endo-α-mannosidase inhibitor and was developed by modification of the known exo-α-mannosidase inhibitor deoxymannojirimycin with an endo-α-mannosidase-targeting 1,3-linked α-glucosyl residue (19, 20) . Inspired by the success of this approach, a new inhibitor, α-glucosyl-1,3-isofagomine (Glc-IFG) (Fig. 1C) , was synthesized (SI Methods) from the broad-spectrum azasugar inhibitor isofagomine, by introduction of a 1,3-linked α-glucosyl residue to capitalize upon beneficial binding interactions in the −2 subsite. Isothermal titration calorimetry (ITC) revealed that BtGH99 binds both Glc-DMJ and Glc-IFG, with K d values of 24 μM and 625 nM, respectively (Fig. 2D) . The inhibition data support the requirement for a 1,3-linked disaccharide occupying the −1 and −2 subsites, which is further supported by analysis of crystal structures of inhibitor-enzyme complexes (see below).
Three-Dimensional Structures of BtGH99 and BxGH99. The crystal structure of a selenomethionine derivative of the B. thetaiotaomicron GH99 endo-α-mannosidase enzyme was solved at a resolution of 1.70 Å (Table S1 ). Crystal structures of the native BtGH99 and a second bacterial homolog BxGH99 were solved by mole- cular replacement at resolutions of 2.00 and 1.90 Å, respectively. Together, the different crystal forms and asymmetric unit contents yield 10 crystallographically independent "views" of the structure. The three-dimensional structures of these bacterial endo-α-mannosidase enzymes reveal a single-domain protein adopting a ðβ∕αÞ 8 barrel fold with a central open cleft formed from extended loop regions linking the secondary structural motifs comprising the catalytic active site, Fig. 2A . These loop regions adopt different conformations in the various structures determined, and given the extended and branching nature of the N-glycan substrate(s), it appears that these large flexible loops are capable of forming stabilizing interactions with the substrate, positioning the scissile α-1,2-mannosidic bond so as to promote catalysis within the active site. Perhaps unsurprisingly given the unique enzymatic activity assigned to GH99, this loop-adorned barrel motif appears unique, with both bacterial GH99 orthologs exhibiting no significant structural and sequence similarity to glycoside hydrolases from other families. Analysis against known structural motifs using the Dali server (21) reveals weak secondary structure matches, the closest being endo-β-1,4-mannanase from Trichoderma reesei (Protein Data Bank ID code 1QNR, Z ¼ 15.9, rmsd 3.1 Å across 233 C α positions, sequence identity ¼ 8%).
The GH99 active center, located at the terminus of a solventaccessible channel near the center of the barrel fold, possesses a cluster of carboxylate side chains likely to play a role in mannosidic bond hydrolysis. In order to help assign potential catalytic function to these residues, a time-course of BtGH99-catalyzed hydrolysis of Glc-ManF was studied by 1 H NMR spectroscopy. Enzymatic hydrolysis of the α-linked C-F bond resulted in the rapid appearance of a product, shown by 2D NOESY analysis to be α-Glc-1,3-α-mannose, thus indicating that GH99-catalyzed substrate hydrolysis occurs with a net retention of anomeric configuration (Fig. S4) . Over several hours, the initial product was observed to undergo mutarotation, isomerizing to an equilibrium mixture of both α-and β-anomers at the reducing-end mannose.
Classical retaining glycoside hydrolases operate through a twostep, double displacement reaction in which a covalent intermediate is formed and then hydrolyzed, via oxocarbenium-ion-like transition states (glycosidase mechanisms recently reviewed in ref. 22) . In most cases, this displacement reaction is achieved by an enzymatic nucleophile such as a carboxylate (aspartate or glutamate) or, as for certain sialidases, a tyrosine residue. In some 2-acetamidoglycosidases (including families GH18, 20, 25, 56, 84, and 85), the nucleophile is the 2-acetamido group of the substrate, which acts in a "neighboring group" participation reaction. For GH99, we initially assumed that the catalytic apparatus of the enzyme comprised a catalytic nucleophile acting to form the covalent glycosyl-enzyme intermediate and a catalytic acid/base, first functioning as a general acid to assist leaving group departure and then as a general base to activate water for nucleophilic attack at the anomeric carbon of the intermediate. Kinetic analysis of three BtGH99 active-center variants, E154A, E329A, and E332A (E156, E333, and E336 in BxGH99), reveals substantial decreases in catalytic activity (Table S2 ). Both the E154A and E329A variants show near zero activity. E332A meanwhile shows reduced activity with observed rate constants indicating an approximate 50-fold decrease in catalytic activity with respect to wild type using the activated Glc-ManF substrate. Against the natural substrate, Glc 3 Man 7 GlcNAc 2 , the same mutant shows zero activity compared to wild type, under matching experimental conditions. In order to gain insight into the functions of the different components of the catalytic apparatus, 3D structures were determined with a bacterial endo-α-mannosidase in complex with inhibitors and the truncated reducing-end product, α-1,2-mannobiose.
Active Site Structure and Catalysis. The apo-BtGH99 crystal form presented a major obstacle to the observation of enzyme-ligand complexes, owing to a large loop region (residues 64-79) projecting into the active-center of another molecule of BtGH99 forming an artefactual crystallographic dimer. Despite considerable effort, attempts to obtain a form of BtGH99 amenable to complex formation proved unsuccessful. A second bacterial ortholog, B. xylanisolvens endo-α-mannosidase, was therefore selected for structural characterization and proved amenable to complex formation, allowing structural determination of binary complexes with Glc-DMJ and Glc-IFG, and ternary complexes with each inhibitor and the reducing-end product α-1,2-mannobiose (Fig. 3) .
Imino and aza sugars have proved instrumental reagents in the glycosidase field (23, 24) both for structural and mechanistic dissection and as templates for therapeutic agents. Deoxynojirimycin-type iminosugars possess a basic nitrogen in place of the endocyclic ring oxygen and are mimics of an oxocarbenium-ion bearing positive charge on the ring oxygen position. Isofagominetype azasugars possess a basic nitrogen at the pseudoanomeric position, and can be considered mimics of a glycosyl cation with charge located on the anomeric carbon. These compounds are likely to prove effective inhibitors and high-affinity ligands of the various GH99 endo-α-mannosidase orthologs. The complexes of BxGH99 with Glc-DMJ (25) and Glc-IFG unveil the ligandprotein interactions within the −1 and −2 subsites (18) (Fig. 3) . Both inhibitors bind to the enzyme active site with the −1 ring located deep within a substrate-binding pocket in an undistorted 4 C 1 conformation. The −2 glucosyl residue projects from the catalytic cavity and appears solvent accessible. These subsites lie in the center of a substrate-binding cleft with a length of approximately 40 Å. The solvent-exposed nature of the −2 subsite glucoside allows the accommodation of elongated substrates with additional glucose residues at the 3 position. Aromatic platforms are common binding elements of carbohydrate active enzymes (26) and in these distal negative subsites are provided by a pair of highly conserved tryptophans at positions 48 and 126. Sequence alignments reveal a high degree of sequence conservation across various species in the region comprising the substrate-binding cleft (Fig. 2B) . Indeed, all the interactions in the −2 to þ2 subsites appear to be essentially invariant (Figs. S2 (alignment) and S5 (interactions)). That the glucoside moiety interacts with residues in the −2 subsite, and also with the putative catalytic apparatus, provides a structural rationale for the catalytic requirement of a sugar occupying the −2 subsite of endo-α-mannosidase. Aza and imino sugar inhibitors have been used to identify the catalytic apparatus of glycosidases by virtue of the interactions of potential nucleophiles with the protonated nitrogen atoms (25, 26) . BxGH99 structures in complex with Glc-DMJ and Glc-IFG reveal a water molecule, coordinated by Glu336 (332 in BtGH99) and poised below the pseudoanomeric nitrogen of Glc-IFG and the C1 of the DMJ moiety of Glc-DMJ, in the ideal position for nucleophilic attack to complete the second hydrolysis step of a classical double displacement retention mechanism. Glu336 is situated on the "α-face" of the sugar occupying the −1 subsite, in a position where it might interact with the glycosidic oxygen, thus fulfilling a role strongly indicative of the catalytic acid/base in the enzyme mechanism. Consistent with such a function, the BtGH99 variant E332A retains approximately 2% activity, compared to WT, on the activated fluoride substrate but has no detectable activity on the natural GlcMan 9 GlcNAc 2 glycan (determined by mass spectrometry) or against Glc 3 Man 7 GlcNAc 2 (determined by HPLC).
Isofagomine-type azasugar inhibitors are useful crystallographic probes that typically allow direct observation of the enzymatic nucleophile of retaining glycoside hydrolases. Upon protonation, the pseudoanomeric nitrogen forms a salt bridge with the negatively charged nucleophile, acting as an "ionic trap" for the nucleophile, which during the reaction coordinate must approach within bonding distance of the anomeric carbon (23) . All X-ray structures of retaining glycoside hydrolases with isofagomine-type compounds have, without exception, revealed the catalytic nucleophile to be located within 3 Å of the azasugar nitrogen, whereas for inverting enzymes, the nucleophilic water is found less than 3 Å away from nitrogen (Table S3) . Of particular interest is the absence, in the GH99 orthologs, of any enzymatic carboxylate at a position suitable to act as the enzymatic nucleophile in a conventional double displacement reaction. Indeed, without invoking a conformational change, or repositioning of the −1 sugar residue, the BxGH99 complex structures show no protein residue in a position to act as a potential nucleophile; the most closely located candidates for a classical double displacement mechanism (shown in Fig. 4A ) include the OE1 atom of Glu333 (approximately 3.5 Å distant) or the OH of Tyr46 or Tyr252 (4.0 Å distant). However, none of these residues appear close enough to interact with the inhibitor nitrogens at either ring position in the complexes (Movie S1). Furthermore, the observation of identical (and static) arrangements of the active site residues in three crystal forms of two enzymes with a total of 10 different packing arrangements provides no evidence of intrinsic conformational flexibility within the active site. Provocatively, it is well known that the alkaline solvolysis of α-mannosyl fluoride proceeds through a mechanism involving neighboring group participation in which the 2-OH attacks the anomeric position resulting in the formation of the intermediate 1,2-anhydro-β-mannopyranose. This intermediate is opened by a nucleophile to afford an α-configured product possessing a retained anomeric configuration (27) . Although no evidence currently supports the existence of a 1,2-anhydro sugar as an intermediate for glycosidase-catalyzed hydrolysis, it is possible that such a mechanism may occur with endo-α-mannosidase (Fig. 4B) . Accordingly, the kinetically essential and conserved active-center residue Glu333, poised 2.6 Å away from the O2 group of the substrate, would deprotonate the 2-OH, promoting its nucleophilic attack on C1.
The anti-arrangement of O2 and the leaving group seen in the complex with Glc-DMJ is that stereoelectronically required for epoxide formation, which requires a linear transition state of the attacking nucleophile, the reactive carbon center, and the leaving group. Neighboring group participation by the 2-acetamido group of N-acetyl-β-glycosides is now well established in families GH18, 20, 25, 56, 84, and 85 (28) . Together the precedent for neighboring group participation in these glycoside hydrolase families, the lack of an apparent enzymatic nucleophile in the GH99 structures, and the established neighboring group participation mechanism for nonenzymatic hydrolysis of α-mannosyl fluoride, provides an enticing precedent to suggest this unorthodox enzymatic mechanism. In order to dissect the leaving-group ("positive" numbers; ref. 18 ) subsites of the GH99 endo-α-mannosidase, additional crystallization experiments were conducted with either Glc-DMJ or Glc-IFG together with α-1,2-mannobiose. Such conditions afford complexes with the inhibitors in the −1 and −2 subsites, and with the mannobiose disaccharide in the þ1 and þ2 subsites. As with the −2 moiety, the þ2 mannose residue appears solvent accessible, projecting outside the active site cavity at a distance of approximately 7 Å from α-1,3-glucose, consistent with an ability to accommodate the remaining reducing end residues of a complex N-glycan. Phenylalanines at positions 253 and 258 provide an aromatic platform positioning the þ1 mannoside, with Tyr289 and Asn298 making hydrogen-bonding interactions with the O3 and O4 positions of the same sugar. Likewise within the þ2 subsite, hydrogen bonding occurs between O3 and O4 and Tyr195, Asp196, and Tyr198. Despite the sugar residue occupying the þ1 subsite appearing to be slightly displaced from its likely true position during hydrolytic cleavage of the authentic substrate (O2 of the þ1 sugar lies approximately 4 Å from the atom equivalent to the anomeric C1 of the residue in the −1 subsite in both inhibitor complexes), both structures show the carboxylate group of the likely catalytic acid/base, Glu336, to be in close proximity to the position of the scissile α-1,2-mannosidic bond.
Discussion
Endo-α-mannosidase is a resident of the cis/medial compartment of the Golgi apparatus and pre-Golgi intermediates, and is a membrane-associated protein that is difficult to recombinantly express in soluble form (29) . The bacterial orthologs from B. thetaiotaomicron and B. xylanisolvens are soluble proteins and may have been acquired by horizontal gene transfer because these organisms are common and beneficial components of the human gut (30) . It has been suggested that, under normal conditions, endo-α-mannosidase acts to deglucosylate folded Glc 1 Man 7-9 glycoproteins that may reach the Golgi apparatus through being poor substrates for ER α-glucosidase II (7). The biological role of the bacterial enzymes is unclear, but may include, as is the case for the exo-α-mannosidases of family GH92 (31), mannose foraging for basic metabolic inputs. Just as incomplete deglucosylation in the mammalian cell prevents the action of exo-α-mannosidases, a similar problem with the bacterial exo-α-mannosidases might have led to the beneficial acquisition of the enzyme by the bacteria. It is notable that whereas the genomes of B. thetaiotaomicron and B. xylanisolvens possess many copies of the N-glycan active exo-α-mannosidases (24 and 17 GH92 enzymes, respectively; 3 GH125 enzymes each) each genome contains only a single copy of a GH99 enzyme, which supports its role in relieving a metabolic bottleneck in the degradation of glucosylated N-glycans. Alternatively, or additionally, the bacterial endo-α-mannosidase may act on yeast mannans, which contain the epimeric α-mannosyl-1,3-mannose substructure. In this regard, it is interesting that studies of mammalian endo-α-mannosidase have indeed shown that α-mannosyl-1,3-deoxymannonojirimycin, the epimer of Glc-DMJ, is an effective inhibitor (20) .
Mammalian endo-α-mannosidase has a preference for monoglucosylated N-glycans and its activity increases as the number of mannose residues on the 6′-mannose branch decreases (16) . The structures of the bacterial orthologs suggest that the majority of substrate specificity is for the −1 and −2 subsites with additional sugars off the 3-position of the −2 glucose residue likely to project into solvent and not to be involved in significant enzyme interactions. α-Mannosidases must overcome certain substrate-specific challenges to achieve effective catalysis because the enhanced anomeric effect in mannose deters substrate distortion, and thus an attacking nucleophile suffers destabilizing 1,2-diaxial interactions with the axial 2-OH group. In retaining GH38 (32) , and inverting GH47 (33) GH92 (31) α-mannosidases, a divalent metal ion (Zn 2þ for GH38, Ca 2þ for GH47 and GH92) is found to coordinate the 2-and 3-hydroxyls, possibly assisting in catalysis through substrate distortion and in delivery of the nucleophile (31) . By contrast, in the inverting GH125 enzymes no metal ion is observed in any structures and no substrate distortion was seen in a pseudo-Michaelis complex with an S-linked disaccharide spanning the active site (34) . It is unclear how this family overcomes the destabilizing diaxial interaction of the attacking water nucleophile, although it is possible that a favorable hydrogen bond between the 2-OH of the sugar and the nucleophilic water may assist in nucleophilic attack in a similar way to the divalent metals in the GH38, GH47, and GH92 enzymes. A notable feature of the GH99 active site observed in both bacterial endo-α-mannosidase orthologs is the absence of a metal ion or indeed of a site for possible metal ion coordination. The enzyme-inhibitor complexes with Glc-DMJ and Glc-IFG determined for BxGH99 reveal no obvious substrate distortion in the −1 subsite and, despite the presence of an ionic trap in Glc-IFG, no enzymatic nucleophile is apparent. However, a widely conserved residue, Glu333, is found in close proximity to O2, and its mutagenesis results in a near-complete decrease in catalytic activity. Taken together, these observations suggest that the hydrolysis reaction catalyzed by the GH99 endo-α-mannosidase family proceeds via both a metal-independent and possibly a uniquely unorthodox mechanism.
Inhibitors that intervene in early steps of N-glycan biosynthesis have been largely ineffective in suppressing N-linked glycan processing. Cells in which glucosidase II has been inhibited or subjected to genetic knockout retain 40-80% normal N-glycan processing function through the intervention of endo-α-mannosidase (8, 35, 36) . During a castanospermine (CST)-imposed α-glucosidase I and II blockade, HepG2 cells produced N-linked glycoproteins with the normal glycan structure and resulted in concomitant release of free Glc 1-3 Man oligosaccharides (6) . Evidence for the basal action of endo-α-mannosidase in the absence of glucosidase inhibition or knockout was demonstrated through the use of the mannosidase I inhibitor, DMJ, which prevents further processing of the deglucosylated N-linked oligosaccharides. Man 6-8 GlcNAc, but not Man 9 GlcNAc, structures were identified, with the Man 8 GlcNAc structure being the characteristic isomer generated by endo-α-mannosidase cleavage (6) . Coadministration of the α-glucosidase I and II inhibitor CST and the selective endo-α-mannosidase inhibitor Glc-DMJ resulted in inhibition of biosynthesis of Glc 3 Man and N-linked glycoproteins (25) . On the other hand, Golgi α-mannosidase II is seen as a promising target for therapeutic intervention, as this enzyme acts after endo-α-mannosidase rejoins the normal pathway and so acts on all N-linked glycans undergoing processing (25) . Swainsonine, a selective inhibitor of Golgi α-mannosidase II, blocks the abnormal formation of complex oligosaccharides, leading to reduced metastasis and tumor growth (37) . However, swainsonine also inhibits the closely related lysosomal α-mannosidase, limiting its clinical use (38) . Combination therapies of glucosidase I/II inhi-bitors (e.g., 6-O-butanoyl-CST) and endo-α-mannosidase inhibitors may provide a viable alternative approach. The development of Glc-IFG as a more potent inhibitor of the bacterial endo-α-mannosidase serves as a valuable precedent for glucosylation of inhibitors of exo-α-mannosidases to search for more active inhibitors of endo-α-mannosidase, which will be assisted by the structural and mechanistic blueprint provided by this work.
Methods
Gene Cloning, Mutagenesis and Protein Production. The gene encoding BtGH99 was amplified from genomic DNA by PCR and ligated into a modified pET28a vector encoding an N-terminal His 6 -tag (pETLIC-BtGH99). Site-directed mutagenesis was carried out using the QuikChange mutagenesis kit (Stratagene). The gene encoding BxGH99 was constructed from synthesized oligonucleotide fragments (Genscipt, Inc.) and also subcloned into pET28a. Protein production and purification was identical for both Bt-and BxGH99 enzymes, including all respective variants. Escherichia coli BL21 (DE3) cells harboring the GH99-encoding plasmid were cultured in 0.5 L ZYM-5052 autoinduction media (39) supplemented with 50 μg mL −1 kanamycin at 37°C for 8 h, with induction occurring overnight at 16°C. Cells were harvested and resuspended in 50 mM NaH 2 PO 4 , pH 8.0, 300 mM NaCl, and lysed by sonication. Soluble lysate was applied to a NiSO 4 -charged 5 mL HiTrap chelating column (GE Healthcare), preequilibrated in the same buffer. The protein was eluted in an imidazole gradient, dialyzed, concentrated, and further purified on an S75 16∕60 gel filtration column (GE) preequilibrated in 25 mM Hepes, pH 8.0, 50 mM NaCl. The BtGH99 selenomethionine derivative was overexpressed in PASM-5052 media (39) , otherwise all isolation and purification steps were as described above.
Activity, Kinetics and Stereochemistry. GH99 activity on GlcMan 9 GlcNAc 2 was studied by MALDI-TOF mass spectrometry of the permethylated products following overnight incubation at 37°C (see SI Methods). The ligand affinity of BtGH99 for Glc-DMJ and Glc-IFG was analyzed by ITC using an iTC 200 calorimeter (MicroCal). Assays were carried out at 25°C with Glc-DMJ (6.4 mM) and Glc-IFG (3.0 mM) titrated into the ITC cell containing 460 and 370 μM BtGH99, respectively. The dissociation constant for each reaction (K d ) was then calculated using the Origin 7 software package (MicroCal). Kinetic parameters for the hydrolysis of the synthetic substrate α-glucopyranosyl-1,3-α-mannopyranosyl fluoride (Glc-ManF) were determined using a fluoride-selective electrode with NMR analysis used to determine reaction stereochemistry (see SI Methods).
Crystallization, Data Collection, and Structure Solution. The BtGH99 structure was solved using single wavelength anomalous dispersion techniques using the selenomethionyl protein with data collected at beamline I24 of the Diamond Light Source. Other structures were solved by molecular replacement with data collected on beamlines ID23-2 and ID14-1, respectively, of the European Synchrotron Radiation Facility, and at beamlines I04-1 and I03 of the Diamond Light Source. Full details of crystallization, data collection, and structure solution, including programs used, are given in the SI Methods.
